is semaglutide discontinued Semaglutide, a glucagon-like peptide-1 receptor agonist (GLP-1 RA), an increasingly popular medication for improving glycemic control and promoting weight loss in patients with type 2 diabetes or obesity. Although gastrointestinal symptoms Adults with obesity who discontinue

However, its important to keep in mind that while Semaglutide decreases overall body fat, it may not always eliminate every problem area or tighten loose skinmaking a combination of medical weight loss and body contouring an optimal approach for many patients

In rare cases, more serious side effects such as pancreatitis have been reported

July 2, 2024

A key differentiator of Mardrigals resmetirom is that in a pivotal Phase 3 trial, it achieved both primary endpoints of NASH resolution and reduction in fibrosis (MAESTRO-NASH), the two liver histological improvement endpoints the FDA has proposed as reasonably likely to predict clinical benefit

Genome Med 14 , 7 (2022)

both carry rare risks of pancreatitis